comparemela.com

Latest Breaking News On - Pathmaker neurosystems inc - Page 1 : comparemela.com

PathMaker Neurosystems Announces Initiation of First-in-Human Trial in ALS for Non-Invasive Neuromodulation Device

The Neuromodulation Market to grow at a CAGR of 12 02% from 2022 to 2027; The expanding applications of neuromodulation therapies is a major trend- Technavio

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.